Discordantly normal ApoB relative to elevated LDL-C in persons with metabolic disorders: A marker of atherogenic heterogeneity

• Principais autores: Alexander C. Razavi (Autor), Lydia A. Bazzano (Autor), Jiang He (Autor), Marie Krousel-Wood (Autor), Kirsten S. Dorans (Autor), Michael A. Razavi (Autor), Camilo Fernandez (Autor), Seamus P. Whelton (Autor), Tanika N. Kelly (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2021-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Objective: A significant proportion of persons with metabolic syndrome (MetS), prediabetes, or type 2 diabetes (T2D) do not develop atherosclerotic cardiovascular disease (ASCVD).We sought to determine whether discordantly normal apolipoprotein B (ApoB) relative to elevated LDL-C may help to explain...